745 – HIV Drug Resistance by Next-Generation Sequencing After Transition to TLD in Uganda and South Africa
Background Studies have identified an increased risk of dolutegravir (DTG) resistance in people with nucleos(t)ide (NRTI) resistance after transitioning from non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy (ART) to tenofovir/lamivudine/dolutegravir (TLD). However, the frequency of this occurrence in programmatic settings, as well as the impact of NRTI resistance on emergence of DTG resistance minority variants,…